ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 27 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $103,230 | – | 18,872 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 653,870 | $3,432,818 | 0.37% |
| ADAR1 Capital Management, LLC | 201,728 | $1,059,072 | 0.20% |
| Nantahala Capital Management | 477,855 | $2,508,739 | 0.15% |
| Perceptive Advisors | 623,315 | $3,272,404 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 230,790 | $1,211,648 | 0.08% |
| Westside Investment Management, Inc. | 38,762 | $203,505 | 0.05% |
| Fermata Advisors, LLC | 30,949 | $162,482 | 0.04% |
| Laird Norton Wetherby Trust Company, LLC | 33,000 | $173,250 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 14,000 | $73,500 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,774 | $733,935 | 0.00% |